SCHEMBL14048578

SCHEMBL14048578

C/C=C(/C)c1ccc(C(F)(F)F)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 4/20 0.44
▸ NR4A1 P22736 1/20 0.43
▸ NR4A2 P43354 1/20 0.43
▸ NR4A3 Q92570 1/20 0.43
▸ CES2 O00748 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ RXRA P19793 1/20 0.42
▸ RXRB P28702 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ PTGS2 P35354 2/20 0.41
▸ NQO2 P16083 1/20 0.41
▸ CFTR P13569 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CYP1A1 P04798 1/20 0.38
▸ CYP1B1 Q16678 1/20 0.38
▸ TAS2R14 Q9NYV8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22082175 0.79 CES2 (0.42) PTGS1NR4A1NR4A2NR4A3CES2
SCHEMBL18291815 0.78 ALDH1A1 (0.56) NR4A1NR4A2NR4A3CES2KDM4E
SCHEMBL18611579 0.78 CES2 (0.44) PTGS1NR4A1NR4A2NR4A3CES2
SCHEMBL19139880 0.76 CES2 (0.42) PTGS1CES2KDM4EALDH1A1HPGD
SCHEMBL27875939 0.75 TP53 (0.44) GAA
SCHEMBL27520453 0.75 NR4A1 (0.63) PTGS1NR4A1NR4A2NR4A3CES2
SCHEMBL14476277 0.75 NR4A1 (0.63) PTGS1NR4A1NR4A2NR4A3CES2
SCHEMBL424990 0.74 RXRB (0.70) CES2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL3023134 0.74 CES2 (0.53) NR4A1NR4A2NR4A3CES2KDM4E
SCHEMBL8301631 0.74 RXRA (0.47) CES2KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1632483-B1 HETEROCYCLIC SUBSTITUTED CARBONYL DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS AVENTIS PHARMA INC (US) 2008-10-29 — — EP disclosed
Send feedback